U.S. FDA amends J&J vaccine fact sheet to include rare bleeding risk

The U.S. Food and Drug Administration on Tuesday amended the fact sheet for Johnson & Johnson’s (JNJ.N) COVID-19 vaccine to include a rare risk of immune thrombocytopenia, a bleeding disorder.

Read More